APOE4 moderates the association of sleep disturbance with cerebral amyloid burden but not with clinical conversion in cognitively normal older adults.
Journal of Alzheimer's disease : JAD · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansApolipoprotein E4FemaleAgedSleep Wake DisordersMalePositron-Emission TomographyAmyloid beta-PeptidesDisease ProgressionAged, 80 and overBrainAniline CompoundsAlzheimer DiseaseCognitive DysfunctionCognitionNeuropsychological TestsAPOE ε4Alzheimer's Disease Neuroimging InitiativeAlzheimer's diseaseamyloid PETamyloid-βclinical conversioncognitively normal elderlylongitudinal studysleep disturbance
Come citare questo studio
Min Ji Lee, Ji-Hyun Kim, Hye Ji Choi, Musung Keum, Gihwan Byeon, Vin Ryu, Guk-Hee Suh, Jee Wook Kim, Young Min Choe, Alzheimer's Disease Neuroimaging Initiative. (2026). APOE4 moderates the association of sleep disturbance with cerebral amyloid burden but not with clinical conversion in cognitively normal older adults.. Journal of Alzheimer's disease : JAD. DOI: 10.1177/13872877261487625
Consulta la pubblicazione originale ↗